We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Detection Method Spares Unnecessary Prostate Cancer Treatments

By HospiMedica International staff writers
Posted on 18 Apr 2016
A novel three-dimensional (3D) cell model that mimics the morphogenesis of acini, the glandular units that constitute the prostate, could help study how prostate cancer (PC) progresses.

Developed by researchers at St. More...
George's University of London, the 3D cellular model monitors the morphogenesis of the glandular structures using microscopy and imaging techniques, which can help identify the intraluminal hyperproliferation of the acini. By identifying the factors that alter the epithelial organization of acini that lead to the intraluminal proliferation, the researchers hope to develop a strategy that can help determine the causes of PC progression.

Using the 3D acini model, the researchers are developing methods that will provide objective measures for patient stratification and disease grading, which could thus complement current clinical classification of patients diagnosed with PC. By doing so, they hope to be able to consistently distinguish aggressive PC from indolent disease, a distinction currently difficult to identify, which often leads to inappropriate treatment and high morbidity and mortality.

“Based on these cell culture models, we believe a test could be developed to assess how invasive a prostate cell could become when taken from a patient,” said principal investigator Ferran Valderrama, PhD, of the SGUL PC cell biology laboratory. “We believe that this information would help to determine the appropriate treatment for the patient, reducing the burden derived from unnecessary over treatment, and overall having a positive outcome in patient survival.”

“The currently available prognostic tests for prostate cancer cannot conclusively tell us whether a tumor will rapidly progress and spread to other tissues, or instead will remain confined to the limits of the prostate,” added Dr. Ferran Valderrama. “Improving current procedures for predicting the outcome of a prostate that presents with ‘suspicious’ characteristics of prostate cancer are necessary. If we were able to determine that outcome in a consistent and conclusive manner, it would be easier to define the best approach for treatment for each individual case.”

Related Links:

St George's University of London

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.